# Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients

> **NCT02022709** · PHASE4 · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 78 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder
- Anxiety Disorders
- Mental Disorders

## Interventions

- **DRUG:** Fluoxetine
- **DRUG:** Sertraline
- **DRUG:** Paroxetine
- **DRUG:** Citalopram
- **DRUG:** Fluvoxamine
- **BEHAVIORAL:** Exposure and Response Prevention

## Key facts

- **NCT ID:** NCT02022709
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-11-18
- **Final completion:** 2018-03-13
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2022-09-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02022709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02022709, "Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02022709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*